Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9db5428d6823098cb526c6c9db4c1ab5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D261-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D261-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 |
filingDate |
2019-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52c2c78fe697878ced88d9bc1d787e7c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5fcd76a0b3666c00f102c24f7a9f406b |
publicationDate |
2022-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
LT-3823960-T |
titleOfInvention |
ISOXAZOLES AS FXR RECEPTOR AGONISTS |
priorityDate |
2018-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |